Health Care Provider Use ofPlasmodium vivaxRadical Cure with Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru (PAVE Peru)

Objectives

The aim of the study is to investigate whether it is operationally feasible to provide appropriate treatment to P. vivax patients aged ≥6 months after G6PD testing.

Objectives:

• Assess Healthcare Provider adherence to a revised case management algorithm for vivax malaria that involves providing radical cure after semi-quantitative G6PD testing and a follow-up visit. This will be assessed at the provider, patient, and health facility level.
• Determine the ability of Healthcare Provider to safely implement radical cure after semi-quantitative G6PD testing.
• Evaluate the quality and effectiveness of training and supervision strategies to support the implementation of semi-quantitative G6PD testing before radical cure.
• Explore barriers and facilitators at the patient, provider, and facility level that mediate effective use of radical cure with semi-quantitative G6PD testing.
• Determine the costs associated with introducing semi-quantitative G6PD testing before radical cure as part of routine care.